X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (324) 324
humans (288) 288
norpregnadienes - pharmacology (271) 271
index medicus (143) 143
animals (131) 131
obstetrics & gynecology (106) 106
adult (97) 97
ulipristal acetate (80) 80
norpregnadienes - administration & dosage (78) 78
receptors, progesterone - metabolism (69) 69
mifepristone (64) 64
middle aged (61) 61
norpregnadienes - adverse effects (60) 60
norpregnadienes - therapeutic use (60) 60
estradiol - pharmacology (56) 56
pregnancy (56) 56
progesterone (55) 55
pharmacology & pharmacy (54) 54
rats (54) 54
promegestone - pharmacology (51) 51
endocrinology & metabolism (50) 50
receptors, progesterone - drug effects (45) 45
levonorgestrel (43) 43
male (43) 43
megestrol (43) 43
reproductive biology (43) 43
emergency contraception (42) 42
endometrium - drug effects (41) 41
nomegestrol acetate (41) 41
progesterone congeners - pharmacology (41) 41
norpregnadienes - metabolism (39) 39
dose-response relationship, drug (37) 37
megestrol - pharmacology (37) 37
women (37) 37
adolescent (36) 36
ovulation - drug effects (36) 36
contraception, postcoital - methods (35) 35
time factors (35) 35
leiomyoma - drug therapy (33) 33
contraception (32) 32
cdb-2914 (30) 30
estrogen (30) 30
receptors, progesterone - antagonists & inhibitors (29) 29
mifepristone - pharmacology (28) 28
uterine neoplasms - drug therapy (28) 28
ovulation (27) 27
young adult (27) 27
progesterone - pharmacology (26) 26
promegestone - metabolism (26) 26
biochemistry & molecular biology (25) 25
estradiol (25) 25
kinetics (25) 25
progestins (24) 24
progestins - pharmacology (24) 24
expression (23) 23
cell line (22) 22
cell line, tumor (22) 22
cytosol - metabolism (22) 22
progesterone-receptor modulator (22) 22
mice (21) 21
progesterone - metabolism (21) 21
cell proliferation - drug effects (20) 20
contraceptive agents, female - pharmacology (20) 20
endometrium (20) 20
administration, oral (19) 19
efficacy (19) 19
levonorgestrel - pharmacology (19) 19
oncology (19) 19
cells, cultured (18) 18
hormone antagonists - pharmacology (18) 18
menstrual-cycle (18) 18
menstruation (18) 18
norpregnadienes - pharmacokinetics (18) 18
pharmacology (18) 18
postmenopausal women (18) 18
double-blind method (17) 17
estrogens - pharmacology (17) 17
leiomyoma - pathology (17) 17
treatment outcome (17) 17
uterine fibroids (17) 17
analysis (16) 16
apoptosis (16) 16
breast neoplasms - metabolism (16) 16
breast neoplasms - pathology (16) 16
drug combinations (16) 16
estrenes - pharmacology (16) 16
obstetrics and gynecology (16) 16
oral contraceptives (16) 16
rabbits (16) 16
uterine neoplasms - pathology (16) 16
contraceptives, oral - pharmacology (15) 15
contraceptives, postcoital - pharmacology (15) 15
endometrium - metabolism (15) 15
estradiol - administration & dosage (15) 15
ovarian follicle - drug effects (15) 15
uterus - metabolism (15) 15
clinical trials as topic (14) 14
endometrium - pathology (14) 14
estradiol - blood (14) 14
internal medicine (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (356) 356
French (15) 15
Japanese (6) 6
Chinese (5) 5
Italian (4) 4
German (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 2010, Volume 70, Issue 5, pp. 541 - 559
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9714, pp. 555 - 562
Summary Background Emergency contraception can prevent unintended pregnancies, but current methods are only effective if used as soon as possible after sexual... 
Internal Medicine | WOMEN | CONCEPTION | MEDICINE, GENERAL & INTERNAL | PROGESTERONE-RECEPTOR MODULATOR | INTERCOURSE | OVULATION | ABORTION | REGIMEN | MIFEPRISTONE | INCREASED ACCESS | PREGNANCY | Contraceptives, Oral, Synthetic - adverse effects | Meta-Analysis as Topic | Follow-Up Studies | Contraceptives, Oral, Synthetic - therapeutic use | Humans | Middle Aged | Norpregnadienes - administration & dosage | Contraceptives, Postcoital, Hormonal - administration & dosage | Norpregnadienes - pharmacology | Contraceptives, Oral, Synthetic - pharmacology | Contraceptives, Oral, Synthetic - administration & dosage | Adult | Female | Ovulation - drug effects | Contraception, Postcoital - methods | Menstrual Cycle - drug effects | Levonorgestrel - pharmacology | Norpregnadienes - adverse effects | Norpregnadienes - therapeutic use | Contraceptives, Postcoital, Hormonal - pharmacology | Treatment Outcome | Pregnancy | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Contraceptives, Postcoital, Hormonal - adverse effects | Contraceptives, Postcoital, Hormonal - therapeutic use | Coitus | Levonorgestrel - therapeutic use | Contraceptives, Postcoital | Comparative analysis | Health aspects | Levonorgestrel | Birth control | Blister packs | Family planning | Menstruation | Womens health | Conflicts of interest | Meta-analysis
Journal Article
Investigational New Drugs, ISSN 0167-6997, 6/2012, Volume 30, Issue 3, pp. 967 - 980
Journal Article
Journal Article
Journal of Women's Health, ISSN 1540-9996, 07/2017, Volume 26, Issue 7, pp. 728 - 734
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 01/2013, Volume 133, Issue 1, pp. 30 - 42
► Aromatase overexpressing and Letrozole resistant T47D cell lines were generated. ► Antiprogestin, Proellex, suppressed growth of these cells in vitro. ►... 
Breast cancer | Antiprogestin | Aromatase inhibitor | B-ISOFORM | ACTIVATED PROTEIN-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | INHIBITOR RESISTANCE | ESTROGEN-RECEPTOR | GROWTH-FACTOR RECEPTOR | LINE | ENDOCRINOLOGY & METABOLISM | PROGESTERONE-RECEPTOR | POSTMENOPAUSAL WOMEN | EXPRESSION | HORMONAL-THERAPY | Genes, erbB-1 - drug effects | Nitriles - pharmacology | Aromatase Inhibitors - pharmacology | Humans | Aromatase - metabolism | Drug Resistance, Neoplasm | Receptors, Progesterone - genetics | Norpregnadienes - pharmacology | RNA, Messenger - metabolism | Testosterone - pharmacology | RNA, Neoplasm - metabolism | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Aromatase - genetics | Base Sequence | Female | Tumor Stem Cell Assay | Gene Expression | Antineoplastic Agents, Hormonal - pharmacology | RNA, Messenger - genetics | Breast Neoplasms - drug therapy | Cell Adhesion | Triazoles - pharmacology | Progestins - antagonists & inhibitors | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Tamoxifen - pharmacology | Cell Line, Tumor | RNA, Neoplasm - genetics | Promegestone - pharmacology | Cell Proliferation - drug effects | Phosphates | Genes | Cytochrome P-450 | Genetic transcription | Antineoplastic agents | Estradiol | Monosaccharides | Antimitotic agents | Testosterone | Epidermal growth factor | Cancer cells | DNA polymerases | Mifepristone | Nitriles | Progesterone | Sugars
Journal Article